A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.
Trakatelli M, Toungouz M, Blocklet D, Dodoo Y, Gordower L, Laporte M, Vereecken P, Sales F, Mortier L, Mazouz N, Lambermont M, Goldman S, Coulie P, Goldman M, Velu T.
Trakatelli M, et al. Among authors: gordower l.
Cancer Immunol Immunother. 2006 Apr;55(4):469-74. doi: 10.1007/s00262-005-0056-z. Epub 2005 Aug 20.
Cancer Immunol Immunother. 2006.
PMID: 16133111
Free PMC article.
Clinical Trial.